Use access key #2 to skip to page content.
$37.49 0.69 (1.88%)
9/5/2008 3:48 PM

SurModics, Inc. (SRDX)

CAPS Rating:
**

Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating SRDX

Add Stock to Watchlist

What the Community Thinks

Total Members

45 Outperforms
18 Underperforms
 

All-Stars

12 Outperforms
6 Underperforms
 

Wall Street

2 Outperforms
2 Underperforms
 

Members bullish on SRDX are also bullish on:

Members bearish on SRDX are also bearish on:

Ticker Tags

Specialty Chemicals (61), Small Cap (1922), Diagnostic Substances (53)
Suggest a tag

SurModics, Inc. At A Glance

Current Price: $37.49
Last Trade Time: 9/5/2008 3:48 PM
Open: $36.76
Previous Close: $36.80
Daily Range: $36.49 - $37.72
52-Week Range: $36.75 - $56.75
Volume: 305,893
Market Cap: $665.09M
P/E Ratio: 368.00
Compare Our Special Broker Offers!

Stock Trends

SRDX VS S&P 500 (SPY)

SRDX 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for SRDX.

Top Bull Pitch

Recs

1

SurModics, Inc. (SRDX)

Avatar hermitinvestor (53.24) Submitted: 9/13/06 4:33 PM

Versatile, well protected technology makes anyone's medical device better. Major new business coming.

Replies: 2 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 10 :   1 2 Next »

Recs

0

 (SRDX)

Avatar HoldSideAnalyst (< 20) Submitted: 7/30/07 5:23 PM : Outperform Start Price: $47.60 SRDX Score: -4.72

Stent worries overdone. Regardless, this company has real opportunities beyond the stent market.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SRDX)

Avatar aaroger (23.00) Submitted: 7/20/07 5:20 AM : Underperform Start Price: $46.98 SRDX Score: 0.14

53

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SRDX)

Avatar cccruz (22.67) Submitted: 7/06/07 9:38 PM : Outperform Start Price: $52.37 SRDX Score: -9.27

Still has 5 potential opthamology deals to be signed in addition to Merck. Diverse portfolio of customes and products. Great patent coverage. No debt. Recent stock buyback. High short interest due to investors who feel Surmodics is a one trick pony with stents.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SRDX)

Avatar skc0001 (< 20) Submitted: 6/18/07 3:10 AM : Outperform Start Price: $37.90 SRDX Score: 18.24

Proposed by Good People

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SRDX)

Avatar sojournerks (99.50) Submitted: 3/29/07 9:35 PM : Underperform Start Price: $35.45 SRDX Score: -18.75

margins no longer looking impressive and chart action indicates more to the downside

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 10 :   1 2 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackSMHCapital 61.58 07/29/08 Underperform NS $41.48-9.40%-0.86%+8.55
TrackAvondale 94.76 01/14/08 Outperform NS $53.40-29.63%-12.08%-17.55
TrackCLKing < 20 06/28/07 Outperform NS $47.63-21.10%-17.51%-3.59
TrackPiperJaff 79.29 03/20/07 Underperform NS $37.30+0.75%-11.40%-12.15

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners